Late in 2012 I did a piece on the global trends in stem cell clinical trial patterns. It is time for an update. Another look at stem cell clinical trials now (late Sept. 2013) based on the clinicaltrials.gov database shows an encouraging trend. Total Stem Cell Clinical Trials The total number of stem cell clinical […]
Maps of global stem cell clinical trial trends Read More »
How seriously do patients consider stem cell clinical trials? This is the first in a new series of posts I’m doing in lessons I’ve learned from the ever-increasing number of patients who contact me directly or are readers of this blog who make great comments. Today’s post is focused on the lack of availability of
Lessons from patients: stem cell clinical trials unlikely option for most patients Read More »
It seems like just yesterday I was blogging about how concerned I was that iPS cells might be used in early phase human clinical trials as early as next year and that would be high risk given safety concerns about iPS cells. Oh, it was yesterday. Now today….. Yomiuri Shimbun, one of the top newspapers
CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company
CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »